Patents by Inventor Matthew Gumbleton

Matthew Gumbleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ship inhibition to induce activation of natural killer cells
    Patent number: 10702538
    Abstract: The present invention relates to the use of SHIP1 inhibitors and pan-SHIP1/2 inhibitors in various methods, including, without limitation, a method of inhibiting SHIP to induce broad activation of natural killer (NK) cells to treat various diseases.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: July 7, 2020
    Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: William Kerr, Matthew Gumbleton
  • SHIP INHIBITION TO INDUCE ACTIVATION OF NATURAL KILLER CELLS
    Publication number: 20170151262
    Abstract: The present invention relates to the use or SHIP1 inhibitors and pan-SHIP1/2 inhibitors in various methods, including, without limitation, a method of inhibiting SHIP to induce broad activation of natural killer (NK) cells to treat various diseases.
    Type: Application
    Filed: June 17, 2015
    Publication date: June 1, 2017
    Inventors: William Kerr, Matthew Gumbleton
  • SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT
    Publication number: 20170128461
    Abstract: The present invention relates to the use SHIP inhibitors to induce expression of granulocyte colony stimulating factor (G-CSF) in a subject, thereby promoting expansion of hematopoietic and mesenchymal stem cells.
    Type: Application
    Filed: June 17, 2015
    Publication date: May 11, 2017
    Inventors: William Kerr, Matthew Gumbleton